The American Journal of Surgical Pathology · 2012 · 134 citations · 21 references
MedicineOncologyPathologyDiagnostic PathologyHistopathologyNeoplasiaHepatic PathologyHepatocellular CarcinomaMolecular Classification Of TumorsTumor ClassificationAdenomatoid TumorCore Needle Biopsy CorrelationDiagnostic ImmunohistochemistryImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical StainingImmunohistochemistry In Tumor DiagnosisSurgical Specimen Evaluation
Phenotypic identification of focal nodular hyperplasia (FNH) and hepatocellular adenoma (HCA) subtypes using immunohistochemical markers has been developed from their molecular characteristics. Our objective was to evaluate the sensitivity of these markers in the definitive diagnosis of these lesions by core needle biopsies. A total of 239 needle biopsies paired with their surgical resection specimen (group A) or without an associated resection specimen (group B) were reviewed. Using a step-by-step algorithm after standard staining, appropriate immunostaining analyses were performed to determine the certainty of diagnosis of FNH, HNF1α-inactivated HCA, inflammatory HCA, β-catenin-activated HCA, or unclassified HCA. The diagnosis of FNH was certain or probable on routine stains in 53% of needle biopsies of group A, whereas after glutamine synthetase staining, the diagnosis was certain in 86.7% as compared with 100% on the corresponding surgical specimen (P=0.04). In needle biopsies of group A, the diagnosis of HCA was certain on routine stains in 58.6% as compared with 94.3% on surgical specimens. After specific immunostaining, diagnosis was established on biopsies with 74.3% certainty, including all HCA subtypes, with similar distribution in surgical specimens. For each "certain diagnosis" paired diagnostic test (biopsy and surgical specimen), a positive correlation was observed (P<0.001). No significant difference was observed between groups A and B for FNH (P=0.714) or for HCA subtypes (P=0.750). Compared with surgical specimens, immunohistochemical analysis performed on biopsies allowed the discrimination of FNH from HCA and the identification of HCA subtypes with good performance.
21
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
Sandra Rebouissou, Mohamed Amessou, Gabrielle Couchy et al. · Nature · 2008 · 467 citations · Full text
Medicine, Cancer Biology, Oncology +14
Hepatocellular adenoma management and phenotypic classification
Paulette Bioulac‐Sage, H. Laumonier, Gabrielle Couchy et al. · Hepatology · 2009 · 437 citations